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Tubulerizationduct elongates along the Wolfﬁan duct, a mesonephric structure that is required
for Müllerian duct formation. Recently, several genes required for initial Müllerian duct formation have been
identiﬁed. However, the precise mechanism of Müllerian duct elongation remains to be elucidated. In this
study, we investigated dynamic morphological changes in the elongating Müllerian duct in rat urogenital
ridges in organ culture manipulated by microincision and/or chemical inhibitors. Mechanical division of the
developing Müllerian duct showed that epithelial cells of the Müllerian duct actively migrate along the
anterior–posterior axis independent of the proliferative expansion of the anterior portion of the duct. We
found that the PI3K/AKT signaling pathway is activated in the Müllerian duct epithelium and is required for
elongation of the tip of the duct; however, migration of Müllerian duct epithelial cells proximal to the tip
remains intact when PI3K/AKT is inactivated. Although much is known about the molecular and cellular
mechanisms leading to Müllerian duct regression, the present ﬁndings provide a fuller understanding of the
mechanisms contributing to Müllerian duct formation and to the general process of early tubulogenesis.
© 2008 Published by Elsevier Inc.Introduction
The Müllerian duct is the anlage of the female reproductive tract in
mammals giving rise to the oviduct, uterus, and the upper third of the
vagina (Hunter, 1929; Cunha, 1975). During embryonic development,
both sexes form the Müllerian (paramesonephric) duct in the mesone-
phros. Thereafter, the now sexually dimorphic Müllerian duct continues
to grow in the femalewhile it regresses completely in males in response
to Müllerian Inhibiting Substance (MIS) secreted from the testes (Jost,
1947; Picon, 1969; Hayashi et al., 1982; Tsuji et al., 1992; Allard et al.,
2000; Zhan et al., 2006). Müllerian duct formation is divided into three
phases: initiation, invagination, and elongation (Orvis and Behringer,
2007). During the ﬁrst two phases, a group of Lim1 positive coelomic
epithelial cells, at themost anterior part of the mesonephros, invaginate
under the inﬂuence ofWnt4 to commenceMüllerianduct formation. The
third phase begins when the Müllerian duct elongates between the
already formed Wolfﬁan duct and the coelomic epithelium along the
anterior–posterior (A–P) axis (Gruenwald, 1941; Dyche, 1979; Orvis and
Behringer, 2007). The origin of Müllerian duct epithelial (MDE) cells
contributing to the elongation of the duct has been controversial(P.K. Donahoe).
lsevier Inc.(Gruenwald,1941; Frutiger,1969;DelVecchio,1982; Inomataet al.,1989).
However, electron microscopy and genetic fate mapping have demon-
strated that theMDEoriginates exclusively fromthemost anterior part of
the mesonephric coelomic epithelium (Jacob et al., 1999; Guioli et al.,
2007; Orvis and Behringer, 2007). It has also been demonstrated, by
extirpation or blockage of the Wolfﬁan duct in the chick and by mouse
mutations, that the Wolfﬁan duct is required for Müllerian duct
elongation (Gruenwald, 1937; Bishop-Calame, 1966; Didier, 1971, 1973;
Kobayashi et al., 2005; Pedersen et al., 2005). Mice mutant for either of
the transcription factors Lim1, Emx2, and Pax2, all of which are needed
for Wolfﬁan duct development, are devoid of Müllerian ducts (Torres et
al., 1995; Miyamoto et al., 1997; Kobayashi and Behringer, 2003;
Kobayashi et al., 2004). In addition, mutations in Wnt9b, which is
expressed in theWolfﬁan duct but is not required for its formation, also
lead to Müllerian duct dysgenesis. Although Wnt9b null mice exhibit
normalWolfﬁan duct development, Müllerian duct elongation, the third
phase of its formation, is absent, suggesting that Wnt9b acts as a
diffusible signal required for the duct elongation (Carroll et al., 2005).
Thus,Müllerian duct development is not only dependent on the physical
presence of the Wolfﬁan duct, but also on signals emanating from it.
The highly proliferative state of MDE cells along the entire
elongating Müllerian duct is thought to be a major contributor to its
extension along the A–P axis (Jacob et al., 1999; Guioli et al., 2007).
Although passive propulsion driven by intense proliferation is likely a
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it is also possible that a strong stimulus from additional guidance
signals is needed to move and direct the MDE cells.
While the genes involved in Müllerian duct formation have been
well studied, the signaling pathways responsible for Müllerian duct
development are less well understood. The phosphatidylinositol 3-
kinase (PI3K)/AKT pathway is known to play major roles in cell
proliferation, inhibition of apoptosis, cell adherence, and migration, in
normal development and in many malignant neoplasms (reviewed by
Krasilnikov, 2000; Vivanco and Sawyers, 2002). Although the PI3K/
AKT pathway is known to be activated in the epithelial cells of
developing ureter, lung, and submandibular gland, and is essential for
proper tube formation and branching, especially budding of the
epithelium into surroundingmesenchyme (Tang et al., 2002; Larsen et
al., 2003; Steinberg et al., 2005; Wang et al., 2005), the status of the
PI3K activity in the Müllerian duct has not been investigated. The
basement membrane of the Müllerian duct epithelium can be
detected early in the formation of the duct (Gruenwald, 1941; Jacob
et al., 1999). Components of the basement membranes are known to
stimulate receptor tyrosine kinases (Panayotou et al., 1989; Vogel et
al., 1997; reviewed by Tran et al., 2004), and to activate the PI3K/AKT
pathway. Hurst et al., (2002) showed that, at a later embryonic stage,
the MDE cells express epidermal growth factors receptor (EGFR)
(Okano et al., 2000), which also can activate the PI3K/AKT pathways.
These reports suggested the PI3K/AKT pathway might be activated in
the Müllerian duct.
In the present study, we investigated cell movement in the
developing Müllerian duct epithelium in the rat urogenital ridge by
mechanically dividing the Müllerian duct into segments by micro-
incisions into the mesonephros. This dissection isolated a group of
distal MDE cells (see methods and Fig. 1) from the anterior portion of
the duct, following which we observed the effects on elongation and
progression of theMüllerian duct over a speciﬁed time course in organ
culture (Donahoe et al., 1977; Zhan et al., 2006). During this process,
we investigated the status of the PI3K/AKT pathway in the MDE, and
by using chemical PI3K inhibitors, examined the dependence of
Müllerian duct development, particularly its elongation, on this
pathway. Our results suggest that, in addition to active proliferation,
cell migration is also an important mechanism for Müllerian duct
development. This MDE cell migration is PI3K/AKT independent whileFig. 1. The rat urogenital ridge and the method for making incisions in the mesonephros to d
indicates the direction of Müllerian duct elongation along the A–P axis. (B) Higher magniﬁc
schematic deﬁning of the image in (B). The lateral edge of the mesonephros was incised with
site of the incision is determined by a set distance from the Müllerian duct tip (X μm anterior
posterior; g, gonad; m, mesonephros.Müllerian duct tip elongation and subsequent mesonephric develop-
ment are PI3K/AKT dependent.
Materials and methods
Animals, harvesting of urogenital ridges, micromanipulation, and organ
culture
Urogenital ridges (Fig.1A)were obtained from the embryos of timed
pregnant Sprague–Dawley rats (Harlan) and studied at developmental
stages from embryonic day E13.5 to E16.5. With the aid of a dissecting
microscope, transverse incisions were madewith a #11 scalpel blade in
the lateral edge of the urogenital ridges deep enough to sever the
Wolfﬁan duct (Fig. 1C); the growing Müllerian duct tip was detected by
rolling the specimen (Fig. 1B), and incisions were made at a set distance
anterior or posterior to theMüllerianduct tip (RedArrow, Figs.1B andC).
Tissues were cultured at the air/ﬂuid interface on 2% agarose coated
stainless steel grids for up to 48 h or submerged for up to 16 h in
CMRL1066 medium (Life Technologies) supplemented with 10% female
fetal bovine serum, penicillin, and streptomycin at 37 °C in 5% CO2 in a
humidatmosphere. In all experiments, at least twourogenital ridgeswere
treated per condition, and each experimentwas repeated at least 3 times.
All animal protocols were approved by the Massachusetts General
Hospital Internal Review Committee on the use of animals and
experiments (IACUC approval #2005N000281/2).
Fixation of tissues and preparation of slides
Tissues were ﬁxed in 4% paraformardehyde in phosphate buffered
saline overnight at 4 °C. For preparing permanent sections, tissues were
treatedwith increasing concentrations of alcohol andxylene, embedded in
parafﬁn, and sectioned at 6 μm. For frozen sections, ﬁxed tissues were
treated with increasing concentrations of sucrose up to 35%, then
embedded in Tissue Freezing Medium (Triangle Biomedical Sciences),
frozenat−20 °C, and8 μm(BrdUstaining) or 10 μmsections thenprepared.
Whole mount in situ hybridization
Whole mount in situ hybridization was used for visualizing the
Müllerian duct (Zhan et al., 2006). Fixed tissues were dehydrated,ivide the Müllerian duct. (A) Rat urogenital ridges were harvested at E14.5. Blue arrow
ation of the whole mount image of the distal tip of the Müllerian duct (box in A). (C) A
a scalpel blade, deep enough to sever both the Müllerian duct and theWolfﬁan duct. The
to the tip). Red arrows in (B) and (C) indicate the tip of the Müllerian duct. A, anterior; P,
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re-ﬁxed, pre-hybridized, and then hybridized with mouse Wnt7a
anti-sense digoxigenin labeled riboprobe (1 μg/ml) overnight at
70 °C. After hybridization, tissues were rinsed thoroughly, blocked
with 10% sheep serum, then incubated with anti-digoxigenin-AP
antibody (1:1,500) (Roche Pharmaceuticals, # 1093274) overnight at
4 °C. BM-Purple AP substrate (Roche, # 1442074) was used to
detect the hybridized probe colorimetrically. Samples were subse-
quently cryosectioned at 10 μm. Mouse Wnt7a anti-sense riboprobe
was synthesized from the IMAGE consortium clone (GenBank
Accession Number BC049093) as previously described (Zhan et
al., 2006).
5-bromo-2′-deoxyuridine (BrdU) labeling
Tissues were incubated in the complete medium described above
supplemented with 50 μM BrdU (Sigma, #B-5002) for 30 min to 8 h,
ﬁxed, and then processed for parafﬁn sections, frozen sections, or
whole mount in situ hybridization.
Phosphatidylinositol 3-phosphate (PI3K) inhibition
Urogenital ridges were submerged and incubated in complete
medium with the PI3K inhibitors, LY294002 (Cell Signaling Techno-
logies, #9901) at 1–50 μM and wortmannin (Fluka, #95455) at
10–500 nM, for 30 min to 24 h. Tissues were then ﬁxed and processed
for parafﬁn sections, frozen sections, or whole mount in situ hybrid-
ization as described above.
Histology, immunoﬂuorescence, and immunohistochemistry
For antigen retrieval, sections were microwaved in 0.01 M
sodium citrate (pH 6.0) for 1 min at maximum power then allowed
to cool to room temperature. Prior to staining for BrdU, slides were
incubated in 6% hydrogen peroxide at room temperature for 10 min,
in 20 μg/ml of proteinase K at 37 °C for 20 min, and then in 2 N
hydrochloric acid at 37 °C for 30 min. Slides were blocked with 5%
bovine serum albumin in Tris-buffered saline with 0.1% Tween-20
(TBST) for 1 h at room temperature. Primary antibodies were
diluted in 5% BSA in TBST and applied to the slides for 1 h at room
temperature; primary antibodies include rabbit monoclonal anti-
phosphorylated AKT (Ser 473) (1:100 dilution; Cell Signaling,
#4058), rabbit polyclonal anti-human PAX8 (1:500 dilution; a
kind gift from Dr. R. Drapkin of the Dana Faber Cancer Institute,
Boston), and mouse monoclonal anti-BrdU (1:400 dilution; Sigma,
#B2531). Slides were incubated with secondary antibodies diluted
in TBST for 1 h at room temperature; secondary antibodies included
AlexaFluor 488 goat anti-rabbit IgG or AlexaFluor 555 goat anti-
mouse IgG (1:1000 dilution; Invitrogen), or biotinylated goat anti-
mouse IgG (1:250 dilution; Vector Laboratories, #BA-9200). After
washing, slides were coverslipped with Vectashield with DAPI
(Vector, #H-1200) for immunoﬂuorescence. For BrdU detection,
slides were treated with the Vectastain Elite® ABC kit (Vector, #PK-
6100) and color developed in 3,3-diaminobenzidine in 0.01%
hydrogen peroxide in TBST, then counterstained with eosin. The
6 μm parafﬁn sections were stained with hematoxylin and eosin (H
and E).
Terminal deoxynucleotidyl transferase mediated dUTP-X nick end
labeling (TUNEL)
To detect apoptotic cells by TUNEL staining, either parafﬁn
embedded 6 μm or 8 μm frozen sections were prepared using the In
Situ Cell Death Detection Kit (Roche, #1684795) according to the
manufacturer's instructions. Slides were incubated in 10 μg/ml
proteinase K at 37 °C for 20 min to permit antigen retrieval.Results
Müllerian duct epithelial (MDE) cells actively migrate along the A–P axis
To understand the precise mechanisms of Müllerian duct elonga-
tion, we divided rat mesonephroi into segments by mechanical
incisions and studied Müllerian duct movement in organ culture. At
E14.5 in the developing urogenital ridge, the Müllerian duct, which
can be visualized by whole mount in situ hybridization with Wnt7a
(Miller and Sassoon, 1998: Parr andMcMahon,1998; Zhan et al. 2006),
elongates alongside the previously formed Wolfﬁan duct (Figs. 2A, D,
and G). When a horizontal incision was made into the mesonephros
200 μm posterior to the tip of the elongating Müllerian duct (black
arrow in Fig. 2B), the leading tip of the Müllerian duct migrated to the
incision site in organ culture (black arrow in Fig. 2E) and then enlarged
proportionate to the time of incubation; the Müllerian duct never
extended posterior beyond the point of incision (Figs. 2E and H). In
contrast to the bulbous change at the tip (Fig. 2H), the diameter of the
anterior region of the Müllerian duct remained the same as that
observed along the length of the intact control ridge (Figs. 2D, E and G,
H). Cross sections anterior to the bulbous tip (Fig. 2H, red line) showed
normal MDE morphology (Fig. 2L). Cross sections at the bulbous tip of
the Müllerian duct (solid black line in Fig. 2H) showed an increased
number of the MDE cells, aligned with epithelial polarity (Fig. 2M).
Cross sections at the dashed line in Fig. 2H show small packed cells at
the very tip (Fig. 2N).
When the developing Müllerian duct was divided at two sites (Fig.
2C, black arrows), 200 μm and 700 μm anterior to the tip (red
arrowhead), thereby creating three segments, Wnt7a positive MDE
cells appeared to proceed towards and accumulate at the posterior
end of each segment during incubation, leaving no MDE cell on the
immediate posterior side of each incision site (Figs. 2F and I). The
leading tip of the isolated most posterior segment of the Müllerian
duct shifted towards the caudal end of the mesonephroi at the same
rate as occurred in intact ridges (compare the position of the tips
indicated by the red arrowheads in Figs. 2D and G with F and I).
Bulging of the Müllerian duct just anterior to incision sites and
absence of Wnt7a positive MDE cells just posterior to incision sites,
except for the most anterior segment, were replicated regardless of
the level of incision (data not shown).
At E15.5, theMüllerian duct has reached the urogenital sinus and is
separated from the Wolfﬁan duct by mesenchymal cells (Figs. 2J and
L). When urogenital ridges at E15.5 were incubated after mesonephric
incision, the same ﬁndings, the gap of the Müllerian duct posterior to
the site of incision and the bulge, just anterior to incision were
observed after 20 h of incubation as in E14.5 ridges (compare Figs. 2J
and K with C and I). These results indicate that the MDE cells, during
duct elongation and even after reaching the urogenital sinus, move
actively unless the route is blocked along the A–P axis.
Isolated Müllerian duct tip migrates along the A–P axis without
apoptosis or lateral migration
To understand further the details of MDE cell movement, we
studied a time course of histological changes at a single section level in
the posterior urogenital ridge during elongation of the duct. At E14.5,
the Müllerian duct was divided at 250 μm anterior to the tip (black
arrow in Figs. 3A–D) and transverse sections at 500 μm posterior to
the initial incision site were studied at two-hour intervals for 24 h
(dashed line in Figs. 3A–D at 8 hour intervals).
At initiation of the culture, before the Müllerian duct reached the
observation level (dashed line Fig. 3A), the Wolfﬁan duct, which
expresses PAX8 (Fig. 3I), and the coelomic epithelium were closely
approximated (Figs. 3E and I). Wnt7a was not detected at the
observation level at this time (data not shown). After 8 h, the isolated
posterior portion of the Müllerian duct reached the observation level
Fig. 2. Divided Müllerian duct segments (E14.5–15.5) move caudally without propulsion from a more anterior segment. The Müllerian duct is visualized (A–K) over time by whole
mount in situ hybridization forWnt7a. Intact urogenital ridges harvested at E14.5 (A), and after 10 h (D) or 20 h (G) in organ culture, show normal elongation of the Müllerian duct.
Mesonephroi were incised at 200 μm posterior to the Müllerian duct tip (arrow) at E14.5 (B), and incubated for 10 h (E) or 20 h (H). Elongation was blocked at the site of incision
(arrow) after 10 h and the tip enlarged relative to the time of incubation. The mesonephroi were incised at 200 μm and 700 μm anterior to the Müllerian duct tip (arrows) at E14.5 (C),
and incubated 10 h (F) or 20 h (I). The bulge of the Müllerian duct anterior to the incisions and the Müllerian duct gap posterior to the incisions were seen at each incision site after
10 h. The tip of the most distal segment (red arrowhead) moved at the same rate as did the tip of the intact Müllerian duct (compare D and F; G and I). E 15.5 female rat urogenital
ridges incised at 2 sites (J) and incubated for 20 h (K) similarly showed the bulging tip of the Müllerian duct anterior to the incisions and the gap of the Müllerian duct posterior to the
incisions (J, K) after 20 h. Transverse sections (L–N) of the mesonephros at the levels of the red line (L), black line (M), and dashed line (N) in (H) stained with H and E, show cell
accumulation and enlargement of diameter at (M) and cell accumulation at the distal blocked tip (N) of the Müllerian duct. Arrow, site of incision; red arrowhead, posterior tip of the
Müllerian duct. Scale bar: 500 μm in (A)–(K), 100 μm in (L)–(N).
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coelomic epithelium (Fig. 3F). PAX8 marked the nuclei of both the
Wolfﬁan duct and the Müllerian duct epithelial cells (Fig. 3J). After
16 h, when, for the most part, the isolated Müllerian duct has crossed
the observation level (Fig. 3C), the diameter of the Müllerian duct has
decreased (Fig. 3G). The number of PAX8 stained nuclei in the
Müllerian duct decreased (Fig. 3K) compared to that seen at 8 h (Fig.
3J), and remained along the original line of migration without
scattering. After 24 h, when the isolated MDE cells have passed the
observation level (Fig. 3D), only mesehchymal cells were found
between the Wolfﬁan duct and the coelomic epithelium (Fig. 3H), as
determined by the absence of either PAX8 (Fig. 3L) or Wnt7a staining
(data not shown) The lack of Pax8 or Wnt7a positive cells outside the
line of migration suggested that the MDE cells retained their epithelial
integrity as they migrated and did not move laterally off the A–P
course.
To determine whether apoptosis leads to the disappearance of the
Wnt7a positive MDE cells, we conducted TUNEL staining. MDE cells
exhibited little to no apoptosis as they crossed the observation level(Figs. 3N and O), nor were they seen in the area between the Wolfﬁan
duct and the coelomic epithelium after they have passed that area
(Fig. 3P), indicating that apoptosis does not play a prominent role in
the disappearance of the MDE cells after incision.
Taken together, the caudal shift of the isolated posterior portion of
the Müllerian duct epithelium seems the result of cell migration along
the A–P axis without signiﬁcant apoptosis or lateral migration.
Non-dividing as well as dividing cells contribute to Müllerian duct
elongation
We followed the contribution of dividing, as well as non-dividing
MDE cells to Müllerian duct elongation with BrdU. Urogenital ridges
were incised as described and then incubated with 50 μM of BrdU
continuously. After 8-h of incubation, when the isolated Müllerian
duct tip has shifted posteriorly (Fig. 3B), BrdU negative MDE cells were
still present at the observation level, as visualized by immunohis-
tochemistry (Figs. 3Q and R), indicating that BrdU negative cells
contributed to Müllerian duct elongation by migration, as did BrdU
Fig. 3. The Müllerian duct cell migrates along the A–P axis without lateral migration or apoptosis. Time course of the E14.5 urogenital ridge whose Müllerian duct was divided at
250 μm (arrow) anterior to the tip (red arrowhead). Transverse sections at 500 μm posterior to the initial incision site (dashed line) were studied for 24 h. E14.5 urogenital ridge was
incised in the mesonephros (A) and incubated for 8 h (B), 16 h (C), and 24 h (D), followed bywhole mount in situ hybridization forWnt7a. Transverse sections observed at 0 h (E, I and
M) at the level of the dashed line in (A), after 8 h (F, J, N and Q) in (B), after 16 h (G, K and O) in (C), and after 24 h (H, L and P), of incubation in (D). (E–H) H and E staining. (I–L) PAX8
staining, green; DAPI staining, blue. (M–P) TUNEL staining, green; DAPI, blue. (Q and R) BudU staining of section made at the dashed line in (B) after incubationwith 50 μMof BrdU for
8 h following Müllerian duct division. Migrating tip of the Müllerian duct contains dividing (BrdU) as well as non-dividing (eosin) cells. (R) is a higher magniﬁcation of the dashed
square in (Q). BrdU, brown; eosin, pink. Arrow, initial incision site; red arrowhead, tip of the isolated posterior Müllerian duct. Autoﬂuorescence in the blood vessel was observed in
the mesenchymal area in (I)–(P). Scale bar: 500 μm in (A)–(D), 100 μm, 100 μm in (Q) and 50 μm in (R).
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proliferation contributed to elongation.
PI3K/AKT pathway is highly activated in the Müllerian ducts
PI3K/AKT pathway has been shown to play an important role during
tubulogenesis in other organs (Tang et al., 2002; Larsen et al., 2003;
Steinberg et al., 2005; Wang et al., 2005). Given the cell migration and
rare apoptosis of MDE cells that we observed (Figs. 2 and 3), and the
proximal active proliferation that we and others (Fig. 4B; Jacob et al.,
1999; Guioli et al., 2007) observed, we examined and found that the
PI3K/AKT pathway was activated in the developing Müllerian duct as
measuredbyphosphorylationofAKTwith the anti-Phosphorylated-AKT
(P-AKT) (Ser473) antibody.
P-AKT was consistently detected in the Wolfﬁan duct epithelium,
mesonephric tubules and the gonad from E14.5 to E16.5 in both sexes(Figs. 5A–G). In the Müllerian duct, P-AKT was detected by late E13.5
when Müllerian duct formation has just commenced at the anterior
end of the mesonephros (data not shown). As the Müllerian duct
elongates, P-AKT was detected on the Müllerian duct epithelium from
the funnel shaped anterior end to the posterior leading tip at an
intensity higher than that observed in the adjacentWolfﬁan duct (Figs.
4A and B, female; and E, male). Before the Müllerian duct had fully
elongated and reached the urogenital sinus, there was no sexual
dimorphism in P-AKT level, consistentwith the concept thatMüllerian
duct formation is identical until male speciﬁc regression begins (Orvis
and Behringer, 2007). However, in synchrony with regression of the
Müllerian duct, P-AKT expression decreased (E15.5: Fig. 5F) and
eventually disappeared (E16.5: Fig. 5G) in themaleMüllerian duct, but
remained intense in the female Müllerian duct (Figs. 5C and D).
Consistent with these observations in the rat, we also detected P-AKT
in the Müllerian duct in the mouse from E12 to E14 (data not shown).
Fig. 4. Proliferation and apoptosis of the MDE cells under PI3K inhibition. (A) E14.5 rat
female urogenital ridge stained with whole mount in situ hybridization for Wnt7a with
thick transverse lines indicating the positions examined. After incubation with or
without 25 μM of LY294002 for 2 or 4 h, ridges were ﬁxed, sectioned through and
stained. Five serial sections were selected from the posterior tip of the Müllerian duct
(P), anterior portion where the most anterior portion of the ovary is included (A) and
themid level (M). (B) Percentages of dividedMDE cells were determined in the different
portions of the Müllerian duct after 2-h incubation with or without 25 μM of LY294002.
Divided cells were detected by BrdU, PAX8, and DAPI staining. Six urogenital ridges
were examined (N=6). Columns represent mean percentages ± SD of BrdU positive cells
in the MDE cells with LY294002 (gray columns) and nontreatment (white columns).
Signiﬁcant differences between the proliferating proportion in A, M, and P were
determined by single-factor analysis of variance (ANOVA) and multiple comparison
(pb0.05). A gradual decrease in the proportion of proliferating cells was observed along
the A-P axis, with position A showing a statistically higher proliferation than M and P
(p=0.0004 and 0.00002, respectively). Student's t-test indicated that LY294002 did not
affect the rate of proliferation of the MDE at any position. (C) The percentage of
apoptotic MDE cells was examined in different portions of the Müllerian duct after 4 h
of incubation with 25 μM of LY294002. Apoptotic cells were detected by TUNEL, PAX8,
and DAPI staining. Six urogenital ridges were examined (N=6). Columns represent
mean percentages ± SD of TUNEL positive cells in the Müllerian duct. Statistical analysis
using multiple comparison showed that apoptosis in A was signiﬁcantly less than M
(p=0.04), while P (PL) did not differ signiﬁcantly from M and A.
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While examining the role of the PI3K/AKT pathway in the
development of the Müllerian duct, we noted in E14.5 rat urogenital
ridges in organ culture under the inﬂuence of the chemical PI3K
inhibitors, 0–50 μM LY294002 (Figs. 6B–D) and 10–500 nM wortman-
nin (data not shown), that Müllerian duct elongation was inhibited
after 16 h of incubation in a dose dependent manner. LY294002 is
known to block PI3K and subsequent PI3K-dependent AKT phosphor-
ylation and kinase activity with high speciﬁcity (Vlahos et al., 1994),
while wortmannin, has an irreversible inhibitory effect on a relatively
broad spectrum of substrates (Wymann et al. 1996). Ridges incubated
with vehicle (DMSO) showed normal Müllerian duct elongation,
which approached the posterior end of the mesonephroi of the
explants (white arrowhead in Fig. 6B). However, at concentrations of
10 or 25 μM LY294002, elongation of the Müllerian duct tip failed to
occur beyond the level observed at the start of the incubation (red
arrows in Figs. 6A, C, and D). In doses lower than 10 μM, inhibition of
elongation was not observed (data not shown). When the elongation
was blocked by LY294002, the posterior tip of the Müllerian duct
showed bulging, similar to that observed when Müllerian duct
elongation was blocked by mechanical interruption (compare Figs.
6C and D with 2E and H). The Müllerian duct anterior to the bulge
became thinner (Figs. 6C and D) compared to that observed after
treatment with DMSO (Fig. 6B). The effect observed with LY294002
was recapitulated with 50 and 100 nM of wortmannin in both sexes
(data not shown).
When urogenital ridges were incubated with 0–50 μM LY294002
for 2 h, P-AKT staining by immunoﬂuorescence was clearly reduced in
the Müllerian duct at 10 and 25 μM LY294002 (Figs. 6E, F and G),
concentrations previously reported in other tissue (Larsen et al., 2003;
Steinberg et al., 2005; Wang et al., 2005), indicating that LY294002
targeted PI3K and inhibited AKT phosphorylation.
Urogenital ridges incubated for 4 h with 10–25 μM LY294002 and
visualized at the black line in Fig. 6A showed increased apoptosis in
the Müllerian and the Wolfﬁan duct epithelium (Figs. 6L and M)
compared to the vehicle control in DMSO with no apoptosis (Fig. 6K)
which may explain the smaller diameter of the Müllerian duct after
incubation with PI3K inhibitors for 16 h (compare Figs. 6B, 7B and E,
with 6C, D, 7C and F). When viewed along the entire length of the
duct, the proportion of apoptotic cells in the Müllerian duct was 20–
30% at all levels, after PI3K inhibition (Fig. 4C). Although apoptosis
was induced in both the Wolfﬁan and the Müllerian duct, the effect
on the Müllerian duct seemed stronger than in the Wolfﬁan duct,
which was better maintained than the Müllerian duct after 16 hour
incubation with PI3K inhibitors (data not shown), suggesting that
the Müllerian duct is more susceptible to PI3K inhibition than the
Wolfﬁan duct.
In contrast to the signiﬁcant effects on apoptosis, proliferation in
the Müllerian duct did not appear to be affected by PI3K inhibition
when BrdU incorporation was measured (Figs. 6H, I, and J). After
incubation of the urogenital ridges for 2 h with 0–25 μM of LY294002
in 50 μM of BrdU, transverse frozen sections of the treated urogenital
ridges (10–25 μM) showed that MDE cells actively incorporated BrdU
at all levels of the elongating Müllerian duct (Fig. 4B), as was observed
in DMSO controls (Figs. 6H, I and J). These results suggest that
although proliferation of the MDE cell may not be dependent on the
PI3K pathway, the Müllerian duct requires PI3K activation to inhibit
apoptosis and to stimulate its elongation along the A–P axis.
The migratory movement of the MDE cell is independent of the PI3K/AKT
pathway
When the E14.5 elongating Müllerian duct was divided at a site
500 μm anterior to the tip (black arrow in Figs. 7D–F) and incubated
with 25 μM of LY294002 for 16 h, the Wnt7a positive MDE cells
Fig. 5. Activated PI3K/AKT pathway is in the Müllerian duct. (A) Phosphorylated-AKT (P-AKT) was detected by whole mount immunoﬂuorescence of E14.5 female urogenital ridge
stained with anti-P-AKT antibody. Transverse sections of urogenital ridges at the level of the center of gonads (B–G) stained with anti-P-AKT antibody. E14.5 female (B) and male (E)
show that expression in the Müllerian duct is higher than in theWolfﬁan duct. As the male Müllerian duct undergoes regression (F, G), the intensity of P-AKT progressively decreases
to become undetectable. Autoﬂuorescence of blood vessels was observed in the mesenchymal area in B–G. White arrow, tip of the Müllerian duct; red arrowhead, Müllerian duct;
white arrowhead, Wolfﬁan duct; t, testis; mt, mesonephric tubules; ov, ovary. Scale bar: 500 μm (A), 100 μm (B–G).
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the site of incision (Fig. 7F), where it bulged, as observed in DMSO
controls with incision (Fig. 7E). In LY294002 treated ridges, the leading
posterior tip of the Müllerian duct remained at the initial site
(compare red arrows in Fig. 7D with F), as observed in ridges without
incision (red arrows in Figs. 7A and C), while it moved posteriorly in
DMSO controls (black asterisk in Figs. 7B and E). However, the MDE
cells in the distal segment accumulated at the posterior tip and
generated a blank area between the bulged tip at the incision site and
the trailing edge of the distal segment (Figs. 7E and F), indicating that
cells in the isolated posterior Müllerian duct segment migrated
posteriorly, even in the presence of apoptosis (Fig. 6L). These results
suggest that the migration of each MDE cell is independent of the
PI3K/AKT pathway, while elongation of the tip of the Müllerian duct
requires activation of this pathway.
Müllerian duct insinuation is required for separation of the Wolfﬁan duct
from the coelomic epithelium, and for subsequent mesenchymal
migration between the Wolfﬁan and Müllerian ducts
When theMüllerian duct is elongating along the A–P axis in the rat
mesonephros at E14.5 (Fig. 8A), the Wolfﬁan duct approximates the
coelomic epithelium (Fig. 8I) until the Müllerian duct tip insinuates
between them (Fig. 8E). After 24 h of organ culture (Fig. 8B), the tip of
the Müllerian duct has reached the posterior end of the ridge
separating the Wolfﬁan duct from the coelomic epithelium. Mean-
while, mesenchymal cells migrate in and separate the Wolfﬁan duct
and the Müllerian duct along the length of the A–P axis (red arrow in
Figs. 8F and J).
After 24 h of incubation following mesonephric incision at a site
posterior to the tip, Müllerian duct elongation was interrupted at the
site of incision (asterisk in Fig. 8C). The Wolfﬁan duct failed to detach
from the coelomic epithelium in the area posterior to the incision (Fig.
8K, compare with J), while normal separation occurs in the area
anterior to the incision (Fig. 8G, compare with F). The Wolfﬁan duct
also remains attached to the coelomic epithelium distally after 48 h of
incubation in the same experiments (data not shown).When E14.5 urogenital ridges were incubated with LY294002 for
24 h, elongation of the Müllerian duct was blocked immediately after
adding LY294002, leaving the tip at the initial site (white arrowhead
in Fig. 8D), while the Wolfﬁan duct remained attached to the
coelomic epithelium in the area posterior to the Müllerian duct tip
(Fig. 8L), as observed in the incised ridges (Fig. 8K). In the region
anterior to the tip, mesenchymal cell migration between the Wolfﬁan
and the Müllerian ducts did not occur (Fig. 8H, compare with F and
G). These results suggest that the Müllerian duct insinuation is
required for the separation of the Wolfﬁan duct and the coelomic
epithelium. In addition, separation between the Wolfﬁan and the
Müllerian duct did not occur in urogenital ridges treated with
LY294002, indicating that PI3K activation is required for the
mesenchymal separation of these ducts.
Discussion
Müllerian duct elongation and epithelial cell migration
During Müllerian duct elongation, MDE cells manifest a high rate of
proliferation (Jacob et al., 1999; Guioli et al., 2007), which contributes
signiﬁcantly to the elongation of the duct itself. In this study, we show
that in addition to proliferation,migration ofMDE cells plays an integral
role in the formation of the Müllerian duct. Migration of each MDE cell
implies a driving force, which differs from simple mechanical pressure
caused by volume expansion due to cell proliferation. Chemotaxic
attractants produced at the end of, or as a gradient along, the A–P axis of
the urogenital ridge could cause the MDE cells to move, as observed in
the trachea or lung during branching morphogenesis (Sutherland et al.,
1996; Weaver et al., 2000), or, conversely, there could be a negative
signal from the anterior end of the urogenital ridge, release of which
could propel MDE cells caudally. The fact that the Müllerian duct
elongates normally in the agonadal ridge in organ culture (data not
shown) excludes the gonads andmost caudal tissue as amajor source of
chemoattractants. It is also possible that individual MDE cells are
preprogrammed to migrate cell-autonomously along the A–P axis
independently of chemotaxic signaling. Given that Müllerian duct
Fig. 6. PI3K inhibition blocks Müllerian duct elongation. The E14.5 urogenital ridge (A) was incubated for 16 h with DMSO (B), or with 10 μM (C) or 25 μM (D) LY294002, followed by
whole mount in situ hybridization forWnt7a. The tip of the Müllerian duct remained at the initial position (red arrow) showing bulging after 16 h of incubationwith LY294002 (C and
D), while theMüllerian duct incubatedwith vehicle (DMSO) showed normal elongation (B). Frozen sections taken at the center of E14.5 urogenital ridge (black line in A) after 2 h (E–J)
or 4 h (K–M) of incubation with DMSO (E, H and K), 10 μM (F, I and L) LY294002, or 25 μM (G, J and M) LY294002 were stained by immunoﬂuorescence. Phosphorylated-AKT was
remarkably reduced in the Müllerian ducts treated with LY294002 (E–G). BrdU (green) and PAX8 (red) doublestaining showed no signiﬁcant difference in proliferation of the MDE
cells with LY294002 treatment (H–J). However, TUNEL (green) and PAX8 (red) doublestaining revealed that apoptosis was induced in the Müllerian duct with LY294002 treatment
(K–M). Autoﬂuorescence was observed in blood vessels in the mesenchymal area in (E)–(M). Red arrow, initial position of the Müllerian duct tip before incubation; white arrowhead,
tip of the Müllerian duct after incubation; M, Müllerian duct; W, Wolfﬁan duct. Scale bar: 500 μm (A–C) and 100 μm (E–M).
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1966; Didier, 1971, 1973), it may inﬂuence migratory movement of the
MDE cells by producing attractants or by signaling through cell–cell
adhesion (Jacob et al., 1999). For example, the Wolfﬁan duct product,
WNT9B,was recently identiﬁed as a possible candidate for the induction
of Müllerian duct elongation, since theWnt9b null mice have truncated
Müllerian ducts (Carroll et al., 2005). However, migration of MDE cells
along the A–P axis in the E15.5 mesonephroi (Figs. 2J and K) occurs
without direct attachment either to the coelomic epithelium or the
Wolfﬁan duct (Figs. 5C, D and F). Stimulation and guidance for MDE cell
migration could also come from some component of the extracellular
matrix (ECM) rich region between the coelomic epithelium and the
Wolfﬁan duct (Jacob et al., 1999), such as laminin and collagen (Ikawa et
al., 1984), as observed in tracheogenesis and nephrogenesis (reviewed
by Schock and Perrimon, 2002; Tran et al., 2004).
Migration and division ofMDE cells contribute to the ultimate size of
the Müllerian duct diameter. Once the route is interrupted, migratedMDE cells accumulate and enlarge the duct at the site of interruption
(Figs. 2E, F, H, I, and M), while the diameter becomes smaller in the
isolated posterior tip (Figs. 3F and G). Although apoptosis is one of the
most important mechanisms for determining shape and volume of
tissues or organs (reviewed by Jacobson et al., 1997) and is major
phenomenon inMüllerian duct regression in themale (Price et al.,1977;
Roberts et al., 1999), its role in initial Müllerian duct development is less
signiﬁcant, as few apoptotic cells were observed during (Figs. 3N–P) and
after Müllerian duct elongation in the female (Allard et al. 2000). Taken
together, both proliferation and MDE cell migration are the important
contributing factors to the diameter of the Müllerian duct.
AlthoughMDE cells at all levels seemed to migrate along the A–P axis
(data not shown), depletion ofWnt7a positive cells never occurred at the
most anterior portion where proliferation is highest (Fig. 4B), suggesting
presenceof a steadysourceof cells feeding theentire lengthof theductora
niche where the environment is uniquely suited for maintenance of the
Müllerian duct epithelial stem cells.
Fig. 7. PI3K inhibition blocks elongation of the Müllerian duct but not migration of the MDE cells within the incised duct. The Müllerian duct was visualized by whole mount in situ
hybridization forWnt7a (A–F). E14.5 female urogenital ridge before (A) and after 16 h of incubationwith DMSO (B) or 25 μMLY294002 (C). The tip of the DMSO treatedMüllerian duct
reached the posterior end of the urogenital bulge (asterisk in B), but elongationwas inhibited as the tip remained at the initial position (red arrow) in the ridge treated with LY294002
(C). E14.5 femaleMüllerian duct was divided (black arrow in D), and then incubated for 16 hwith DMSO (E) or 25 μMLY294002 (F). The tip of theMüllerian duct reached the posterior
end (asterisk in E) of the DMSO treated and incised explant; however, elongation was inhibited by the PI3K inhibitor and the tip remained at the initial position (red arrow in F).
Despite failure of elongation, the MDE cells have migrated posteriorly (F) and accumulated at the incision site (black arrow in F) and at the initial site of the tip (red arrow in F),
creating a Wnt7a blank region. Black asterisks mark the elongating tip of the Müllerian duct. Scale bar: 500 μm.
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MDE migration
The high rate of proliferation, rare apoptosis, and the considerable
degree of cell migration, observed duringMüllerian duct development
prompted us to examine the activity of PI3K/AKT pathway in the
urogenital ridge (Krasilnikov, 2000). We ﬁrst conﬁrmed that the PI3K/
AKT pathway was activated in the MDE in the rat (Figs. 5A–G) and the
mouse (data not shown) embryo, during Müllerian duct formation as
previously observed in the epithelium of other developing tubular
organs (Tang et al., 2002; Wang et al., 2005; Larsen et al., 2003).
Using PI3K inhibitors and mechanical microincision, we examined
the roles of PI3K/AKT pathway and showed that the migratory
movement of MDE cells and the elongation of the duct tip are governed
by different mechanisms (Fig. 7), elongation being PI3K/AKT pathway
dependent and migration of the MDE cells along A–P axis being PI3K/
AKT independent (Figs. 6C, D, and 7). Since PI3K inhibitors induce
Müllerian duct apoptosis in less than 25% ofMDE in 4 h (Figs. 6K–M, Fig.
4C), and its susceptibility is not limited to the elongating tip, the
apoptotic mechanism alone seems insufﬁcient to explain the early
cessation of elongation seen with LY294002. Inhibition of enzymatic
reactions might be a reasonable alternative mechanism.
Müllerian duct elongation and modeling of the mesonephros
The Müllerian duct separates the Wolfﬁan duct from the coelomic
epithelium as it elongates in the mesonephros, following which
mesenchymal cells migrate between to separate the Müllerian and
Wolfﬁan ducts (Gruenwald, 1941; Figs. 8E, I and J) via movements
which are perpendicular to the A–P axis (Guioli et al., 2007). This
lateral migration of the mesenchymal cells, however, does not occurwhen Müllerian duct elongation was blocked by either mechanical
incision (Fig. 8K) or PI3K inhibition (Fig. 8L) and is not observed in
Wnt4 knockout mice that fail to form the Müllerian duct, at E13.5
(data not shown), during the interval in which the Müllerian duct of
wild type animals has reached the urogenital sinus. Furthermore,
PI3K inhibition in the tissue results in failure to separate the Wolfﬁan
duct from the Müllerian duct by mesenchymal cell migration (Fig.
8H) suggesting that the PI3K/AKT pathway may be required for this
lateral mesenchymal migration between these epithelial structures
that are early attached to each other via a common basement
mambrane (Jacob et al., 1999). Although the PI3K/AKT pathway is
activated in both the Müllerian duct and the Wolfﬁan duct, given that
the Wolfﬁan duct alone does not induce mesenchymal cell migration
(Fig. 8K), it is probable that the Müllerian duct may have a key role in
remodeling the basement membrane and inducing mesenchymal cell
migration.
The Müllerian duct basement membrane and extracellular matrix
While possibly playing a critical role in a plane perpendicular to the
A–P axis, theMüllerian duct elongates in an ECM rich area between the
Wolfﬁan duct and the coelomic epithelium along the A–P axis (Jacob et
al., 1999). Although the Müllerian duct may use the ECM as a guide, it
may also need to digest or separate thematrices in order to elongate, as
is required of some cancer cells (Giannelli et al., 1997). In Wnt9b null
mice, the Müllerian duct undergoes initial normal invagination, but
does not thereafter elongate along the Wolfﬁan duct (Carroll et al.,
2005), suggesting thatMDE cells in thesemice lack the direction or the
ability to migrate or to break into and through an ECM rich path.
An active enzymatic reaction may be required for ECM digestion or
basement membrane remodeling adjacent to the Müllerian duct
Fig. 8.Müllerian duct insinuation is required for separation of theWolfﬁan duct from the coelomic epithelium, and for subsequent mesenchymal migration between theWolfﬁan and
Müllerian ducts. The Müllerian duct is visualized by whole mount in situ hybridization for Wnt7a. The urogenital ridges at E14.5 (A) were incubated intact (B), incised posterior to
Müllerian duct tip and incubated, (C) or incubated with 25 μM LY294002 without incision (D) for 24 h. White arrowhead indicates Müllerian duct tip at the start of incubation.
Asterisk in (C) indicates the site of incision. Solid line and dashed line indicate sites of histological sections 500 μm anterior and posterior to the tip at E14.5, respectively. Transverse
section histology (E–H) of the mesonephros is observed at the anterior black line in (A)–(D) respectively. Transverse section histology (I–L) is observed at the posterior black dashed
line in (A)–(D) respectively. Mesenchyme separated the Wolfﬁan duct and the Müllerian duct (red arrow in F, G and J), but not in (H). The Wolfﬁan duct stayed attached to the
coelomic epithelium (K and L). W, Wolfﬁan duct; M, Müllerian duct; CE, coelomic epithelium. Scale bar: 500 μm (A–D) and 100 μm (E–L).
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that activation of the PI3K/AKT pathway in the Müllerian duct is
required for these processes, as observed in some endothelial cells and
cancer cells which require this pathway for activation of matrix
metalloproteinases (MMPs) and for migration (Zahradka et al. 2004;
Park et al., 2007). For example, in branching and tubularization in
submandibular gland epithelium in organ culture under FGF7
stimulation, activities of MMPs are increased (Steinberg et al., 2005).
Although we examined the effect of the general MMP inhibitor
GM6001 (Roberts et al., 2002; Steinberg et al., 2005) onMüllerian duct
elongation in organ culture, we observed no effects on this process
(data not shown), probably signifying redundancy of other
proteinases.
Müllerian duct regression and the PI3K/AKT pathway
Although we focused mainly on the development of the Müllerian
duct, our results with PI3K inhibitors suggest that the sexually
dimorphic fate of the Müllerian duct may depend on the PI3K/AKT
pathway. The differential intensity of P-AKT staining in the MDE
between the sexes at the start of regression (Figs. 5C, F and D, G)
suggests that one of the roles of PI3K/AKT pathway in the developing
Müllerian duct may be as a survival factor to prevent apoptosis (Price
et al., 1977; Roberts et al., 1999) and the epithelial–mesenchymal
transitions (Dyche, 1979; Trelstad et al., 1982; Allard et al., 2000, Zhan
et al., 2006), that are major events in Müllerian duct regression. It is
not clear, however, whether suppression of the PI3K pathway in the
male Müllerian duct initiates regression or simply that P-AKT in the
male MDE decreases as a result of regression.Müllerian Inhibiting Substance (MIS), the initiator of Müllerian
duct regression, acts through the MIS type II receptor (reviewed by
Teixeira et al., 2001), which is expressed in the mesenchymal cells
surrounding the MDE in the male after E15.5 in the rat (Catlin et al.,
1992; Teixeira et al., 1996; Zhan et al., 2006; Arango et al., 2008),
resulting in subsequent apoptosis or epithelial–mesenchymal trans-
formation of MDE cells (Dyche, 1979; Trelstad et al., 1982; Allard et al.,
2000). To elicit MIS signaling, some mesenchymal–epithelial interac-
tion must occur (Roberts et al., 1999), which may block the PI3K
pathway in the MDE. In fact, it has been known that MIS blocks early
autophosphorylation of the survival factor, EGF receptor, in the
Müllerian duct epithelium (Hutson et al., 1984; Hurst et al., 2002),
by inhibiting tyrosine kinase (Coughlin et al., 1987), which could result
in PI3K pathway inactivation as a subsequent event.
Conclusion
Our investigations of Müllerian duct formation using PI3K
inhibitors and mechanical incision demonstrate that the MDE cells
actively migrate along the A–P axis and suggest that activation of the
PI3K pathway is required for elongation of Müllerian duct tip,
althoughMDE cell migration is independent of the PI3K/AKT pathway.
Furthermore, Müllerian duct formation and the subsequent develop-
mental events in the surrounding mesenchyme likely occur via PI3K/
AKT activation of the MDE cells. Further investigation is required for a
fuller understanding of the detailed molecular mechanisms. Signaling
or interaction between the Müllerian duct epithelium and surround-
ing ECM may be the key. Understanding precise molecular mechan-
isms contributing to elongation of the Müllerian duct may shed light
361A. Fujino et al. / Developmental Biology 325 (2009) 351–362on the etiology of anomalies of the female reproductive system, such
as the 46XXMayer–Rokintansky–Kuster–Hauser syndrome (reviewed
by Morcel et al., 2007), characterized by Müllerian duct agenesis, and
further, may reveal therapeutics to act in concordance with MIS in the
treatment of Müllerian derived cancers if inhibition of the PI3K/AKT
system plays a role in the initiation of Müllerian duct regression.
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